Cancer patients are at a higher risk of developing blood clots, known as venous thromboembolism (VTE). Elevated D-dimer levels in cancer patients can be indicative of an increased risk of clotting complications. Monitoring D-dimer levels can help in the early detection and management of thrombotic events, which are common in cancer patients due to factors like immobility, surgery, and certain chemotherapy drugs.
